Inherent Biosciences awarded NIH SBIR Phase I Grant to commercialize innovative diagnosis of non-obstructive azoospermia (the most severe form of sperm dysfunction)
Inherent Biosciences announced an award from the National Institute of Child Health and Human Development’s Fertility and Infertility Branch to develop a clinical assay for improved diagnosis of non-obstructive azoospermia (NOA). […]